Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burn

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Human Molecular Genetics|April 1, 1995
Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium)T C Burn, T D Connors, W R Dackowski, et al.
ESMO Open|December 3, 2022
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterationsK Murugesan, A Necchi, T C Burn, et al.
Journal of Biomolecular Screening|March 14, 2007
High-throughput determination of mode of inhibition in lead identification and optimizationMin Wei, Richard Wynn, Gregory Hollis, et al.
The Journal of Biological Chemistry|August 25, 2000
Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctinJ E Dinchuk, N L Henderson, T C Burn, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolinesBrent Douty, Brian Wayland, Paul J Ala, et al.
The Journal of Molecular Diagnostics : JMD|February 17, 2022
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic ProfilingIan M Silverman, Meijuan Li, Karthikeyan Murugesan, et al.
Haematologica|October 30, 2016
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosisJohn O Mascarenhas, Moshe Talpaz, Vikas Gupta, et al.
Gene|June 14, 2002
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promotersReid M Huber, Kathleen Murphy, Bowman Miao, et al.
Protein Expression and Purification|October 26, 2001
A comprehensive system for protein purification and biochemical analysis based on antibodies to c-myc peptideM C Hillman, L S Yang, S Sun, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitorsRichard B Sparks, Padmaja Polam, Wenyu Zhu, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Human Molecular Genetics|April 1, 1995
Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium)T C Burn, T D Connors, W R Dackowski, et al.
ESMO Open|December 3, 2022
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterationsK Murugesan, A Necchi, T C Burn, et al.
Journal of Biomolecular Screening|March 14, 2007
High-throughput determination of mode of inhibition in lead identification and optimizationMin Wei, Richard Wynn, Gregory Hollis, et al.
The Journal of Biological Chemistry|August 25, 2000
Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctinJ E Dinchuk, N L Henderson, T C Burn, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolinesBrent Douty, Brian Wayland, Paul J Ala, et al.
The Journal of Molecular Diagnostics : JMD|February 17, 2022
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic ProfilingIan M Silverman, Meijuan Li, Karthikeyan Murugesan, et al.
Haematologica|October 30, 2016
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosisJohn O Mascarenhas, Moshe Talpaz, Vikas Gupta, et al.
Gene|June 14, 2002
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promotersReid M Huber, Kathleen Murphy, Bowman Miao, et al.
Protein Expression and Purification|October 26, 2001
A comprehensive system for protein purification and biochemical analysis based on antibodies to c-myc peptideM C Hillman, L S Yang, S Sun, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitorsRichard B Sparks, Padmaja Polam, Wenyu Zhu, et al.
Pageof 13